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echocardiographic analysis, her pulmonary arterial systolic
pressure had decreased to 34 mm Hg, and left ventricular
ejection fraction had increased to 55%. There was only
trace tricuspid valve regurgitation.
DISCUSSION
The patient described had parietal pericardial bovine bio-
prostheses in both the mitral and aortic valve positions for 77
months and during that period developed huge quantities of
calcium on the cusps of the bioprosthesis in the aortic valve
position and only small quantities of calcium on the cusps of
the bioprosthesis in the mitral valve position. Because the
closing pressure on the mitral bioprosthesis is usually about
a third higher than that on the aortic bioprosthesis (peak left
ventricular systolic pressure vs end-diastolic aortic pressure;
normally approximately 120 vs 80 mm Hg), it might be ex-
pected that the degeneration of a bioprosthesis in the mitral
position would be greater (more calcium and more tears)
and more rapid than that of a bioprosthesis in the aortic posi-
tion, but the opposite was the case in the patient described
herein. Why might that be the case? Some possibilities in-
clude the following:
1. Parietal pericardial bovine bioprostheses are not the same
as porcine aortic valve bioprostheses. The former are
thicker and less flexible and possibly withstand the left
ventricular peak systolic pressure and the aortic end-dia-
stolic pressure more easily than the more delicate porcine
aortic cusps.
2. The bovine bioprosthesis in the aortic position was defec-
tive and not properly prepared, whereas the one in the
mitral position was not.
3. The febrile illness the patient had beginning 11 months
after the initial cardiac operation could have been active
infective endocarditis that affected the bioprosthesis in
the aortic position but not the bioprosthesis in the mitral
position.
4. Smaller bovine parietal pericardial bioprostheses calcify
more rapidly and more extensively than do larger bovine
pericardial bioprostheses.
5. The paravalvular leak in the mitral position and the ab-
sence of a leak in the aortic position provided a ‘‘bypass
shunt,’’ diminishing the effect of the full force of the peak
left ventricular systolic pressure on the bioprosthetic
cusps in the mitral position.
None of these 5 possibilities can be proved or disproved,
but this report might stimulate careful follow-up of similar
patients to determine whether this distribution of calcium
in the 2 left-sided bioprostheses is a pattern or an exception.
Reference
1. Warnes CA, Scott ML, Silver GM, Smith CW, Ferrans VJ, Roberts WC. Compar-
ison of late degenerative changes in porcine bioprostheses in the mitral and aortic
valve position in the same patient. Am J Cardiol. 1983;51:965-8.
Brief Research ReportsIs minimized extracorporeal circulation effective to reduce the need
for red blood cell transfusion in coronary artery bypass grafting?
Meta-analysis of randomized controlled trials
Umberto Benedetto, MD, Emiliano Angeloni, MD, Simone Refice, MD, Fabio Capuano, MD,
Massimo Goracci, MD, Antonino Roscitano, MD, and Riccardo Sinatra, MD, Rome, ItalyFrom the Cardiac Surgery Department, II School of Medicine, University of Rome
La Sapienza, Policlinico S. Andrea, Rome, Italy.
Received for publication Dec 2, 2008; accepted for publication March 23, 2009;
available ahead of print May 25, 2009.
Address for reprints: Umberto Benedetto, MD, Cardiac Surgery Department, II School
of Medicine, University of Rome ‘‘La Sapienza,’’ Via di Grottarossa 1039 (E-mail:
u2benedetto@libero.it).
J Thorac Cardiovasc Surg 2009;138:1450-3
0022-5223/$36.00
Copyright  2009 by The American Association for Thoracic Surgery
doi:10.1016/j.jtcvs.2009.03.0421450 The Journal of Thoracic and Cardiovascular SPerioperative red blood cell (RBC) transfusion is the single
factor most consistently associated with an increased risk of
postoperative morbid events after isolated coronary artery
bypass grafting (CABG), and each unit of RBC transfused
is associated with incrementally increased risk for adverse
outcome.1 Miniaturized extracorporeal circulation (mini-
ECC) has been proposed to limit perioperative blood prod-
uct use. Mini-ECC consists of a closed ECC system with
no cardiotomy suction or venous reservoir. The rationale is
to avoid air blood contact and minimize priming volume,
thus reducing hemostasis alteration and intraoperativeurgery c December 2009
Brief Research Reportshemodilution. However, there is still controversy on whether
such a strategy effectively reduces postoperative RBC trans-
fusion, with some reports showing no evident benefit.
We conducted a meta-analysis on available randomized
controlled trials (RCTs) to evaluate whether mini-ECC de-
creases the risk of postoperative RBC transfusion com-
pared with conventional ECC in patients undergoing
CABG.
MATERIALS AND METHODS
All RCTs comparing results of isolated CABG on mini ECC versus
conventional ECC were identified using a 2 level search strategy. First,
a public domain database (MEDLINE) was searched using a Web based
search engine (PubMed). Second, relevant studies were identified through
a manual search of secondary sources, including references of initially
identified articles and a search of reviews and commentaries. The MED
LINE database was searched from January 1966 to June 2008. MeSH key
words included ‘‘coronary artery bypass, mini extracorporeal circulation,
mini cardiopulmonary bypass’’ and ‘‘randomized controlled trials.’’ Stud
ies considered for inclusion2 12 met the following criteria: The design was
an RCT, the patients were randomly assigned to mini ECC versus conven
tional ECC CABG, and the study reported the postoperative RBC transfu
sion rate or the amount of RBCs transfused per patient. When several RCTs
reported on the same patient material, only the most recent article was
included.
Two reviewers (U.B. and E.A.) independently abstracted the data. For
each study, data regarding postoperative RBC transfusion rate were used
to generate risk difference; data regarding the amount of RBCs transfused
TABLE 1. Randomized controlled trials enrolled
First author Publication
Mini-ECC
no. of
patients
Conventional
ECC
no. of patients
Abdel Rahman3 Ann Thorac Surg.
2005;80:238 44
101 103
Beghi4 Ann Thorac Surg.
2006;81:1396 400
30 30
Huybregts2 Ann Thorac Surg.
2007;83:1760 7
25 24
Kamiya5 Interact Cardiovasc
Thorac Surg.
2006;5:680 2
10 10
Kofidis6 Perfusion. 2008;
23:147 51
50 30
Liebold7 J Thorac Cardiovasc Surg.
2006;131:268 76
20 20
Ohata8 ASAIO J. 2008;54:207 9 34 64
Perthel9 Eur J Cardiothorac Surg.
2007;31:1070 5
30 30
Remadi10 Am Heart J. 2006;
151:198.e1 e7
200 200
Skrabal11 J Thorac Cardiovasc
Surg. 2006;132:291 6
10 10
Wippermann12 Eur J Cardiothorac
Surg. 2005;28:127 32
10 10
ECC, Extracorporeal circulation.The Journal of Thoracic and Caper patient were used to generate unbiased Hedges’ g (<0 favors mini
ECC; >0 favors conventional ECC). The 95% confidence intervals
(CIs) were based on the asymptotic normality of the combined estimates.
Publication bias was evaluated using the Begg and Mazumdar rank cor
relation test. The pooled summary effect estimate was calculated by
means of a fixed effect model. I2 values were evaluated to assess hetero
geneity, and a value greater than 50% was considered as indicative of
heterogeneity. Meta regression (method of moments) was used to deal
with the possibility of effect modification by patient risk profile (including
age, female gender, number of grafts, ECC time) on the study estimates of
effect size.
RESULTS
Our research identified 11 RCTs (including 1051 patients)
that compared mini-ECC (n ¼ 520) with conventional ECC
(n¼ 531) CABG and that reported the RBC transfusion rate
or the amount of RBC transfused per patient (Table 1).
Pooled analysis showed that mini-ECC decreased the risk
of RBC transfusion (risk difference,0.10; 95%CI,0.15 to
0.005; P< .0001) and the amount of RBC transfused per
patient (Hedges’ g,0.25; 95% CI,0.428 to0.07; P ¼
.005) (Figure 1).
Heterogeneity was absent for the RBC transfusion rate
(I2 ¼ 39%) but not for the amount of RBC transfused per
patient (I2 ¼ 78%). The number of grafts (b ¼0.09; P ¼
.01) and ECC time (b ¼ 0.005; P ¼ .01) but not age
(P ¼ .42) and female gender (P ¼.96) influenced effect
size estimates. No publication bias was found for postoper-
ative RBC transfusion rate (P¼ .50) and the amount of RBC
transfused per patient (P ¼ .22).
DISCUSSION
Mini-ECC has been proposed to reduce postoperative
RBC transfusion when compared with conventional ECC.
However, among available RCTs, 7 of 11 failed to show
a significant benefit. The present analysis, pooling data
from RCTs, demonstrated an absolute risk reduction of
RBC transfusion in patients receiving mini-ECC. In addi-
tion, this advantage was more evident as the complexity
of procedure increased (higher number of grafts performed
and prolonged ECC time). The lack of a significant benefit
in some RCTs may be partially explained by their limited
sample size. Because blood transfusion is reduced by
approximately 30% with a lower priming volume,2 the ap-
propriate sample size should be at least 20 patients for each
arm to obtain a study power of 0.80. Of note, 3 of 7 RCTs
showing no advantages had only 10 patients for each arm.
Abdel-Rahman and colleagues3 observed no benefit in
study with a large sample size. The authors used a hepa-
rin-uncoated minimized circuit that is no longer commer-
cially available, and the latest mini-ECC systems with
a fully heparin-coated closed circuit are associated with re-
duced hemostasis alterations secondary to blood contact
with artificial surfaces.rdiovascular Surgery c Volume 138, Number 6 1451
Brief Research ReportsFIGURE 1. Forest plot for RBC transfusion rate (top) and the amount of RBCs transfused per patient (bottom). Squares indicate individual trial, and lozenges
indicate pooled summary effect estimate. Risk difference and Hedges’ g are displayed on a logarithmic scale. ECC, Extracorporeal circulation;CI, confidence
interval; MECC, mini extracorporeal circulation; CECC, conventional extracorporeal circulation.CONCLUSIONS
This meta-analysis showed mini-ECC reduces postopera-
tive RBC transfusion in patients undergoing CABG.
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